earnings
confidence high
sentiment positive
materiality 0.75
Prestige Q4 revenue $296.5M, adj EPS $1.32; FY25 adj EPS $4.52; FY26 outlook $4.70-4.82
Prestige Consumer Healthcare Inc.
2025-FY EPS
reported $4.29
vs consensus $1.16
▲ beat
(+271.2%)
- Q4 revenue $296.5M (+7.0% YoY, organic +7.9%); diluted EPS $1.00 GAAP, adjusted $1.32 (vs $1.02 prior year).
- FY2025 revenue $1,137.8M (+1.1%); diluted EPS $4.29 GAAP, adjusted $4.52 (+7.4% vs $4.21 prior year).
- Free cash flow $243.3M in FY2025 (+1.6% YoY); leverage ratio reduced to 2.4x at year-end.
- Initial FY2026 outlook: organic revenue growth ~1-2%, diluted EPS $4.70-4.82, free cash flow $245M or more.
- Management guides mid-to-high single-digit EPS growth despite ~$15M tariff headwind.